Women’s Entrepreneurship Accelerator Partners with the WE Empower UN SDG Challenge to Maximize the Development Impact of Women Entrepreneurs
20.11.2021 16:00:00 EET | Business Wire | Press release
The Women’s Entrepreneurship Accelerator (WEA), a strategic multi-partnership convening five United Nations agencies and Mary Kay, Inc., in support of last week Global Entrepreneurship Week and Women’s Entrepreneurship Day, announced a partnership with WE Empower UN SDG challenge, a first-of-its-kind competition for women social entrepreneurs across the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211120005125/en/
Women’s Entrepreneurship Accelerator Logo (Graphic: WEA)
WEA is designed to maximize the development impact of women entrepreneurship in achieving the UN Sustainable Development Goals (SDGs) by creating an enabling ecosystem for women entrepreneurs that fosters growth, sustainability, and resilience. UN Partners of WEA include International Labour Organization (ILO), International Trade Centre (ITC), UN Global Compact (UNGC), UN Development Programme (UNDP), and UN Women.
The WE Empower UN SDG Challenge is a global business competition for women entrepreneurs who are advancing the UN Sustainable Development Goals and inspiring entire communities to act to create the world they want by 2030. The WE Empower UN SDG Challenge honors women entrepreneurs who are advancing the SDGs through their business practices. The opportunity recognizes their innovative work, ignites awareness about the valuable contribution women entrepreneurs can make toward the SDGs, and provides awardees with capacity-building training sessions and connections with business experts around the world.
The programme elevates and showcases the valuable contributions women entrepreneurs and business leaders can make toward the SDGs and solving the world’s greatest challenges. WE Empower is co-led by Vital Voices and Julie Ann Wrigley Global Futures Laboratory at ASU and supported by partners at Bank of Montréal (BMO), Diane von Furstenberg, the G5 Collective, GroYourBiz, Hawaii Tropical Botanical Garden, Mary Kay, Inc., Oxford University Said Business School, Procter & Gamble, Salesforce, UN Foundation, and the World Bank.
“The WE Empower SDG Challenge powerfully showcases women entrepreneurs as ideal role models demonstrating positive business, social and environmental performance,” said Deborah Gibbins, Chief Operating Officer at Mary Kay, Inc. “The Women’s Entrepreneurship Accelerator is honored to partner with WE Empower, a consortium of over 70 partners joining forces for an even greater multiplied impact.”
“We are thrilled to celebrate our partnership with the Women’s Entrepreneurship Accelerator, co-founded by WE Empower lead partner Mary Kay, Inc.,” said WE Empower UN SDG Challenge co-chair & ASU Julie Ann Wrigley Global Futures Laboratory’s Amanda Ellis. “Women entrepreneurs are valuable solutionaries for the UN SDGs and the global 2030 agenda, and WEA unlocks a suite of valuable support tools to help amplify positive impact.”
Globally, women already comprise one-third of all business owners, making critical economic and social contributions, despite the systemic barriers they face. Only five percent of countries legislate for full gender equality, making the support tools provided by the Women’s Entrepreneurship Accelerator even more important. In June 2021, WEA joined the Generation Equality Forum in Paris as well as the Action Coalition on Economic Justice and Rights, and committed to empower five million women entrepreneurs around the world by 2030 to accelerate progress for gender equality.
During UN General Assembly (UNGA 76), WEA announced the launch of a series of impactful initiatives and knowledge products - all shaped through a gender lens. WEA’s impact work includes digital capacity building tools and training, entrepreneurship and policy research, and gender-responsive procurement (GRP) advocacy and training. In October, WEA also announced a milestone partnership with the Commonwealth Businesswomen’s Network (CBWN) aiming at advancing women entrepreneurship in 54 countries of the Commonwealth.
About the Women’s Entrepreneurship Accelerator
The Women’s Entrepreneurship Accelerator (WEA) is a multi-partnership initiative on women’s entrepreneurship convening 5 UN agencies, International Labour Organization (ILO), International Trade Centre (ITC), UN Global Compact (UNGC), UN Development Programme (UNDP), UN Women and Mary Kay, Inc. to empower 5 million women entrepreneurs by 2030.
The ultimate goal of the initiative is to maximize the development impact of women entrepreneurship in achieving Sustainable Development Goals (SDGs) by creating an enabling ecosystem for women entrepreneurs around the world. The Accelerator exemplifies the transformational power of a multi-partnership of unique magnitude to harness the potential of women entrepreneurs.
Learn more at we-accelerate. Follow us: Twitter (@We_Accelerator), Instagram (@we_accelerator), Facebook (@womensentrepreneurshipaccelerator), LinkedIn (@womensentrepreneurshipaccelerator)
About WE Empower UN SDG Challenge
The WE Empower UN SDG Challenge is the first-of-its-kind global competition for women social entrepreneurs who are advancing the UN Sustainable Development Goals and inspiring entire communities to act to create the world we want by 2030. The WE Empower Challenge honors innovative women leaders from around the world who are pushing the SDGs forward through sustainable business practices and inspiring others to follow suit. The opportunity recognizes their innovative work and provides Awardees with capacity-building training sessions and opportunities to connect with an unparalleled global network to advance their enterprises. This program elevates and showcases the valuable contribution women entrepreneurs and business leaders can make toward the SDGs and solving the world’s greatest challenges.
About Vital Voices Global Partnership
Vital Voices Global Partnership is an international non-profit organization that identifies and partners with creative and fearless women leaders around the world. Vital Voices searches the world for women leaders with daring vision for change, then works with them to make that vision a reality. We are venture catalysts, who provide leaders with capacity building, skills training, grants, access to a network of their peers, mentorship, visibility, recognition, and guidance to accelerate change on a global scale. For more than 20 years, Vital Voices has invested in over 18,000 women leaders from 182 countries and territories, who have then gone on to create change affecting millions around the world. Vital Voices works with women who advance economic opportunity, increase political and public engagement, end gender-based violence and promote human rights through signature fellowships, individualized investments and meaningful, lifelong partnerships. Vital Voices connects women solving problems in their communities and equips them with the tools they need to incite global, positive change and accelerate shared progress for all. Visit www.vitalvoices.org to learn more.
About Julie Ann Wrigley Global Futures Laboratory at ASU
The Julie Ann Wrigley Global Futures Laboratory at Arizona State University represents the urgent belief that we can and must make a meaningful contribution to ensuring a habitable planet and a future in which well-being is attainable. The Global Futures Laboratory is the world’s first laboratory dedicated to the health of the planet and its inhabitants. It is built upon the deep expertise of ASU and leveraging an extensive network of partners for an ongoing and wide-ranging exchange across all knowledge domains to address the complex social, economic and scientific challenges spawned by the current and future threats from environmental degradation. This platform positions a new world headquarters for an international array of scientists, scholars and innovators and lays the foundation to anticipate and respond to existing and emerging challenges and use innovation to purposefully shape and inform our future. For more information visit globalfutures.asu.edu.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211120005125/en/
Contact information
Mary Kay Inc. Corporate Communications
marykay.com/newsroom
(+1) 972.687.5332 or media@mkcorp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 11:00:00 EEST | Press release
OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 13:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202613.6.2026 00:31:00 EEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 19:36:00 EEST | Press release
IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
